Midkine as a prognostic biomarker in oral squamous cell carcinoma.
about
Involvement of midkine in neuroblastoma tumourigenesisERβ-mediated estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine.Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma.Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.Midkine: a novel prognostic biomarker for cancer.Midkine in the pathology of cancer, neural disease, and inflammation.Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.Midkine expression in oral squamous cell carcinoma and leukoplakia.Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma.Midkine confers Adriamycin resistance in human gastric cancer cells.The clinical and prognostic significance of midkine in breast cancer patients.Midkine Mediates Intercellular Crosstalk between Drug-Resistant and Drug-Sensitive Neuroblastoma Cells In Vitro and In Vivo.Midkine and NANOG Have Similar Immunohistochemical Expression Patterns and Contribute Equally to an Adverse Prognosis of Oral Squamous Cell Carcinoma.Midkine neurite growth-promoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma.Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis.
P2860
Q27026748-A9DEE803-1BA8-43BA-9E99-EB511B713C0BQ33636340-B019C9E5-390D-4254-AE55-D89AA1B985DAQ35927823-38FE6A5C-0AC3-4D13-A8D5-89248DE54C54Q36706828-993FA9F3-83F6-4C7E-A9F5-6B2AFA1236CAQ37328317-03248DD9-6D10-4CFA-B7A3-7C86D0C3DF40Q38020971-27A17A88-0FE9-435F-9801-F288B2CFB479Q38181600-8218EA8C-7A7E-4DCD-807F-A70173E24D55Q39105827-3B39718D-3CEC-4F4E-98FB-69F81B552064Q39162733-A2E506F9-6D56-42BD-ABD7-1ACB60C5847FQ39350211-5614BE11-4E13-430A-B468-BA28A8C36AC1Q40753164-51B40991-84E2-4500-865E-BF15EB560535Q42257541-43D4B2C3-F0AE-454C-9796-C9D85575BB44Q47167242-3A07565F-7A23-43C3-9525-F29E3BA9AF84Q54237862-61501748-313C-41ED-BEB3-688F0AAEB9AAQ54280198-74A5E38C-4B5C-4383-A5F2-0280F08B11E1Q55110685-A978A24D-1C8D-40C3-A567-F31DD1F28376
P2860
Midkine as a prognostic biomarker in oral squamous cell carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Midkine as a prognostic biomarker in oral squamous cell carcinoma.
@en
type
label
Midkine as a prognostic biomarker in oral squamous cell carcinoma.
@en
prefLabel
Midkine as a prognostic biomarker in oral squamous cell carcinoma.
@en
P2093
P2860
P356
P1476
Midkine as a prognostic biomarker in oral squamous cell carcinoma
@en
P2093
H Fujimori
H Sugiuchi
M Shinohara
S Shiniriki
Y Fukuyoshi
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604539
P407
P577
2008-08-01T00:00:00Z